PMHS

distress 7/10 · high distress / dilution risk

$0.08-32%today-90% from 52w high

polomarsp.com6 employeesLos Angeles, CAPharmaceutical Retailers

Revenue

pre-revenue

Liquidity

$0M

Runway

0.3 yrs

Shares 1y

+0%

Price & events

-90.0% over 6M

CatalystRating changeDilutionFinancingdashed = today

-32.2%

-44.0%

-33.3%

-90.0%

-81.0%

-91.8%

-100.0%

-99.9%

All

Overview

Market Cap: $2.24M
Volume: 1.00K
52 Week Range: $0.07 – $0.80
Total Shares: 28.05M
Float Shares: 14.19M
% Held by Insiders: 50.44%
% Held by Institutions: 0.00%
RVOL: 9.75x

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 28,053,090 · 1 offerings/1y · 0 PIPEs

2026-05-158-Kmaterial_agreement
2025-12-19424B3offering
2025-12-128-Kmaterial_agreement
2025-12-12EFFECTshelf_effective
2025-12-08S-1/Ashelf_registration
2025-12-05S-1/Ashelf_registration
2025-10-148-Kmaterial_agreement

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified